LA
RDY icon

Legacy Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Legacy Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.01M Buy
+3,125
New +$43.1K 0.1% 161

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Legacy Advisors's RDY Position: Q1 2025 in Review

Legacy Advisors opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2025: 3,125 shares worth $1.01M. The stake represents 0.1% of the portfolio and ranks #161 among its holdings.

246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Legacy Advisors held 3,125 shares of Dr. Reddy's Laboratories worth $1.01M as of Q1 2025.
  • Dr. Reddy's Laboratories was a new Legacy Advisors position in Q1 2025.
  • Dr. Reddy's Laboratories made up 0.1% of Legacy Advisors's portfolio in Q1 2025, its #161 holding.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.